Antihypertensive effects of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine on on plasma renin activity and catecholamine responses in spontaneously hypertensive rats

Abstract

Fourteen 23 week old male spontaneously hypertensive rats (SHR) were randomly divided into saline control or phospholipid (1-hexadecyl-2-acetyl- sn -glycero-3-phosphocholine) treatment groups. Four weeks of baseline systolic blood pressure (SBP) and heart rate (HR) measurements were determined via tail plethysmography. On week 25 of the baseline period a 1.5 ml blood sample was taken by tail clip for analysis of norepinephrine (NE), epinephrine (E), and plasma renin activity (PRA). On the following week, a single injection of phospholipid (11 ug/kg, s.c.) was given to the experimental animals following baseline SBP and HR determinations. A similar procedure was employed for control subjects, except they received an injection of normal saline (0.5 ml, s.c). Systolic BP and HR responses were monitored for 24 minutes following the injection. A 1.5 ml blood sample was taken at the end of the 4th minute for NE, E, and PRA assays. A significant drop in SBP (202 ± 5 mmHg to 124 ± 6 mmHg) and an increase in HR (431 ± 17 bpm to 519 ± 21 bpm) were observed for experimental animals, but not for control subjects. Plasma NE increased significantly (446 ± 42 pg/ml to 1099 ± 77 pg/ml), but E remained unchanged following treatment with the phospholipid. Plasma renin activity increased for both groups, but this change was only significant for the experimental group (18.1 ± 5.7 ng Al/ml/hr to 34.3 ± 3.6 ng Al/ml/hr). Thus, it appears that 1-hexadecyl-2-acetyl- sn -glycero-3-phosphocholine i is a potent antihypertensive vasodilating agent which stimulates baroreceptor mediated sympathetic discharge to the heart and kidneys of the SHR.